In this respect, treatment with MRS1220 reduced the transcripts of 29 genes that could tentatively favor the tumor phenotype; three targets that promote chemoresistance, LIMD1, TRIB2, and TGFB1, were distinguished. Here, TGFB1 is linked to neoplasm.